MWG Management Ltd. Activity Q4 2020-Q3 2023

Q2 2023
 Value Shares↓ Weighting
BEAM NewBEAM THERAPEUTICS INC$74,937,6032,346,93445.33%
LYEL NewLYELL IMMUNOPHARMA INC$64,116,21620,162,33238.79%
NewPRIME MEDICINE INC$26,255,8771,792,21015.88%
Q4 2022
 Value Shares↓ Weighting
BEAM ExitBEAM THERAPEUTICS INC$0-2,346,934-43.07%
LYEL ExitLYELL IMMUNOPHARMA INC$0-20,162,332-56.93%
Q2 2022
 Value Shares↓ Weighting
LYEL NewLYELL IMMUNOPHARMA INC$131,458,00020,162,33259.13%
BEAM NewBEAM THERAPEUTICS INC$90,850,0002,346,93440.87%
Q4 2021
 Value Shares↓ Weighting
ILMN ExitIllumina Inc$0-337,102-16.58%
RELX ExitRELX PLCsponsored adr$0-40,254,832-22.06%
BEAM ExitBeam Therapeutics Inc.$0-2,362,635-24.93%
LYEL ExitLYELL IMMUNOPHARMA INC$0-20,298,522-36.43%
Q3 2021
 Value Shares↓ Weighting
LYEL SellLYELL IMMUNOPHARMA INC$300,418,000
-9.0%
20,298,522
-0.2%
36.43%
+12.3%
RELX SellRELX PLCsponsored adr$181,952,000
-52.1%
40,254,832
-7.5%
22.06%
-40.9%
ILMN NewIllumina Inc$136,732,000337,10216.58%
VIR ExitVIR BIOTECHNOLOGY INC$0-74,743-0.35%
Q2 2021
 Value Shares↓ Weighting
RELX NewRELX PLCsponsored adr$380,096,00043,539,02037.34%
LYEL NewLYELL IMMUNOPHARMA INC$330,147,00020,329,23532.44%
BEAM NewBeam Therapeutics Inc.$304,095,0002,362,63529.88%
VIR NewVIR BIOTECHNOLOGY INC$3,534,00074,7430.35%

Compare quarters

Export MWG Management Ltd.'s holdings